 |
The Journal of Neuroscience, February 11, 2004, 24(6):1446-1450; doi:10.1523/JNEUROSCI.3987-03.2004
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation
Stacy A. Castner2,3 and
Patricia S. Goldman-Rakic1
1Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06510, 2MIICRO, Inc., Chicago, Illinois 60607, and 3Departments of Psychiatry and Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60612
A natural consequence of aging is a loss of dopamine function and associated deficits in working memory in both human and nonhuman primates. Specifically, deficiency of D1 receptor signaling has been implicated in age-related cognitive decline. Here, we report that an intermittent, sensitizing regimen of the D1 dopamine agonist ABT-431 dramatically enhances working memory performance in aged rhesus monkeys, while either producing impairment or having little effect on performance in young adult monkeys. Importantly, cognitive enhancement in the aged monkeys was still evident for >1 year after cessation of D1 treatment. Because intermittent exposure to low doses of amphetamine and other stimulants has been shown to enhance responsiveness to subsequent stimulant exposure, our findings suggest that sensitization of D1 signaling may provide a novel neurobiological mechanism for improving a core cognitive process in conditions in which dopamine function has deteriorated, such as in normal aging and Parkinson's disease.
Key words: spatial working memory; nonhuman primate; D1 agonist; sensitization; aging; D1 dopamine receptors
Received Aug 28, 2003;
revised November 27, 2003;
accepted December 1, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
H. Takahashi, M. Kato, H. Takano, R. Arakawa, M. Okumura, T. Otsuka, F. Kodaka, M. Hayashi, Y. Okubo, H. Ito, et al.
Differential Contributions of Prefrontal and Hippocampal Dopamine D1 and D2 Receptors in Human Cognitive Functions
J. Neurosci.,
November 12, 2008;
28(46):
12032 - 12038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gray and B. L. Roth
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Schizophr Bull,
September 1, 2007;
33(5):
1100 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Buchanan, R. Freedman, D. C. Javitt, A. Abi-Dargham, and J. A. Lieberman
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
Schizophr Bull,
September 1, 2007;
33(5):
1120 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Yang and L. Chen
Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment
Neuroscientist,
October 1, 2005;
11(5):
452 - 470.
[Abstract]
[PDF]
|
 |
|
|